Secondary Stroke Prevention in Atrial Fibrillation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Secondary Stroke Prevention in Atrial Fibrillation

Published:2018-06 Issue:6 Volume:49 Page:1315-1317
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Gurol M. Edip¹

Affiliation:

1. From the Department of Neurology, Massachusetts General Hospital, Boston.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Link

https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.118.021262

Reference5 articles.

1. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

2. Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk

3. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

4. Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy

5. Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation;Scientific Reports;2024-04-29

2. Calidad de atención en el manejo de enfermedad cerebrovascular isquémica aguda posterior a la iniciativa angels;Revista Repertorio de Medicina y Cirugía;2024-04-08

3. Effectiveness and safety of secondary prevention of non-vitamin K oral anticoagulants use by drug type in Asian patients;International Journal of Stroke;2023-05-21

4. Secondary stroke prevention in atrial fibrillation: Still lacking pace?;International Journal of Cardiology;2019-06

5. Effectiveness and safety of rivaroxaban in nonvalvular atrial fibrillation: data from a contemporary Spanish registry;Current Medical Research and Opinion;2019-04-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3